Implementation of risk enhancers in ASCVD risk estimation and hypolipidemic treatment eligibility: A sex-specific analysis

Objective: Sex-specific data are limited regarding eligibility for hypolipidemic treatment. We aim to explore the sex-specific clinical utility of high-sensitivity C-reactive protein (hsCRP) and carotid ultrasound as risk modifiers for hypolipidemic treatment in primary prevention of atherosclerotic...

Descripció completa

Dades bibliogràfiques

Autors principals:	Georgios Georgiopoulos, Dimitrios Delialis, Evmorfia Aivalioti, Vasileios Georgakis, Georgios Mavraganis, Lasthenis Angelidakis, Dimitrios Bampatsias, Elena Armeni, Eleni Maneta, Raphael Patras, Maria Angeliki Dimopoulou, Ermioni Oikonomou, Ioannis Kanakakis, Irene Lambrinoudaki, Areti Lagiou, Panos Xenos, Kimon Stamatelopoulos
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2023-09-01
Col·lecció:	Hellenic Journal of Cardiology
Matèries:	Primary prevention Carotid plaque C-reactive protein Hypolipidemic treatment eligibility Sex-specific trends
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1109966623000295
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!